HTG Molecular Diagnostics, Inc. (HTGM) financial statements (2022 and earlier)

Company profile

Business Address 3430 E. GLOBAL LOOP
TUCSON, AZ 85706
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments21,94328,69633,03031,1149,96911,81331,495
Cash and cash equivalents9,60022,3987,6208,4339,9697,5083,294
Short-term investments12,3436,29825,41022,681 4,30528,202
Restricted cash and investments  3,270    
Receivables2,0921,5893,1645,0136,3561,377716
Inventory, net of allowances, customer advances and progress billings1,9881,4921,2701,3071,1811,5112,201
Inventory1,9881,4921,2701,3071,1811,5112,201
Prepaid expense      235
Deferred costs  14059350 
Other undisclosed current assets1,1631,094493509440384210
Total current assets:27,18732,87141,36838,00117,94815,13434,858
Noncurrent Assets
Operating lease, right-of-use asset1,3451,0091,209
Property, plant and equipment1,1191,2272,2402,3743,3053,2701,932
Long-term investments and receivables      2,604
Long-term investments      2,604
Restricted cash and investments   3,270   
Deferred costs   5935052
Other noncurrent assets80990302    
Other undisclosed noncurrent assets   67   
Total noncurrent assets:3,2742,3273,7525,7703,3083,3204,588
TOTAL ASSETS:30,46135,19845,11943,77121,25618,45439,447
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,6722,8093,5335,2086,1862,4322,669
Accounts payable1,6491,3491,6631,8502,439762725
Accrued liabilities2,0231,4601,8703,3583,7471,6701,945
Deferred revenue125185426
Debt5,1683,0223,747 5,7946,3903,059
Asset retirement obligation5485131,1521,290496605544
Deferred revenue and credits66633647
Contract with customer, liability333
Other liabilities172341186200259 
Other undisclosed current liabilities414685     
Total current liabilities:9,9447,2368,8997,01713,34210,0216,320
Noncurrent Liabilities
Long-term debt and lease obligation6,1598,9857,5089,6792,9615,3897,790
Long-term debt, excluding current maturities5,1798,5686,8729,6792,9615,3897,790
Finance lease, liability3148 
Operating lease, liability949369636
Liabilities, other than long-term debt3,9894,5404,7435,9838,0138,6378,444
Asset retirement obligations3,9014,4794,4995,7037,5218,0178,415
Other liabilities886024428049262029
Other undisclosed noncurrent liabilities(49)(48)     
Total noncurrent liabilities:10,10013,47712,25115,66210,97414,02616,234
Other undisclosed liabilities17      
Total liabilities:20,06120,71321,15022,67924,31624,04722,553
Stockholders' equity
Stockholders' equity attributable to parent, including:10,40014,48523,97021,092(3,060)(5,593)16,893
Preferred stock00     
Common stock8558291487
Treasury stock, value     (75)(75)
Additional paid in capital218,723205,662194,234172,087131,493110,081 
Accumulated other comprehensive income (loss)25(5)(3) (1)(41)
Accumulated deficit(208,333)(191,188)(170,318)(151,020)(134,566)(115,606)(89,566)
Other undisclosed stockholders' equity attributable to parent      106,569
Total stockholders' equity:10,40014,48523,97021,092(3,060)(5,593)16,893
TOTAL LIABILITIES AND EQUITY:30,46135,19845,11943,77121,25618,45439,447

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues8,9078,54919,20421,50414,7605,1334,042
Revenue, net14,7605,1334,042
Cost of revenue(4,095)(3,992)(8,911)(5,090)(4,972)(4,136)(3,336)
Cost of goods and services sold(4,095)(3,992)(8,911)(5,090)(1,609)(2,197)(893)
Gross profit:4,8124,55710,29316,4139,788997706
Operating expenses(22,636)(24,143)(29,253)(32,573)(27,510)(25,328)(19,596)
Operating loss:(17,824)(19,586)(18,960)(16,159)(17,723)(24,331)(18,890)
Nonoperating income (expense)701(1,270)(334)(291)(1,234)(1,698)(2,498)
Interest and debt expense(1,065)(522)(958)(105)(1,308)(54)(705)
Loss from continuing operations before equity method investments, income taxes:(18,187)(21,378)(20,252)(16,555)(20,265)(26,083)(22,093)
Other undisclosed income from continuing operations before income taxes1,0655229581051,30854705
Loss from continuing operations before income taxes:(17,123)(20,856)(19,294)(16,450)(18,957)(26,029)(21,388)
Income tax expense(22)(14)(3)(4)(3)(10)(10)
Net loss attributable to parent:(17,145)(20,870)(19,298)(16,454)(18,960)(26,040)(21,398)
Preferred stock dividends and other adjustments      (1,166)
Other undisclosed net loss available to common stockholders, basic      (163)
Net loss available to common stockholders, diluted:(17,145)(20,870)(19,298)(16,454)(18,960)(26,040)(22,726)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(17,145)(20,870)(19,298)(16,454)(18,960)(26,040)(21,398)
Other comprehensive income (loss)(3)10(2)(3)140(41)
Comprehensive loss:(17,149)(20,860)(19,299)(16,457)(18,959)(25,999)(21,439)
Other undisclosed comprehensive loss, net of tax, attributable to parent      (1,329)
Comprehensive loss, net of tax, attributable to parent:(17,149)(20,860)(19,299)(16,457)(18,959)(25,999)(22,768)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: